Q4 2025 Holdings
Filed 2026-02-17 | 116 holdings | $5.6B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Surrozen Inc(SRZNW) | *W EXP 08/01/203 | 86889P117 | $3.3K | 166,666 | 0.0% |
| Ensysce Biosciences Inc(ENSC) | COM NEW | 293602504 | $79.7K | 86,666 | 0.0% |
| Revolution Medicines Inc(RVMDW) | *W EXP 12/17/202 | 76155X118 | $235.0K | 250,000 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $416.9K | 152,714 | 0.0% |
| Envveno Medical Corporation | COM | 29415J106 | $564.3K | 1,759,035 | 0.0% |
| Biodesix(BDSX) | COM | 09075X207 | $739.1K | 108,694 | 0.0% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $800.0K | 50,000 | 0.0% |
| Palatin Technologies Inc(PTN) | COM NEW | 696077601 | $1.1M | 70,000 | 0.0% |
| Medline Inc(MDLN) | COM CL A | 58507V107 | $1.2M | 28,000 | 0.0% |
| Cumberland Pharmaceuticals I(CPIX) | COM | 230770109 | $1.4M | 341,087 | 0.0% |
| Lexeo Therapeutics Inc(LXEO) | COM | 52886X107 | $1.4M | 139,835 | 0.0% |
| Immix Biopharma Inc(IMMX) | COM | 45258H106 | $1.8M | 338,941 | 0.0% |
| Connect Biopharma Hldgs LTD(CNTB) | SHS | G23549101 | $2.2M | 792,696 | 0.0% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $2.5M | 139,667 | 0.0% |
| SAB Biotherapeutics Inc(SABS) | COM NEW | 78397T202 | $3.0M | 803,210 | 0.1% |
| Outset MED Inc(OM) | COM NEW | 690145206 | $3.1M | 833,333 | 0.1% |
| Schrodinger Inc(SDGR) | COM | 80810D103 | $3.6M | 202,400 | 0.1% |
| Olema Pharmaceuticals Inc(OLMA) | COM | 68062P106 | $4.1M | 165,713 | 0.1% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $4.3M | 121,082 | 0.1% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $4.3M | 17,500 | 0.1% |
| Tango Therapeutics Inc(TNGX) | COM | 87583X109 | $4.5M | 513,035 | 0.1% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $4.8M | 747,193 | 0.1% |
| Tectonic Therapeutic Inc(TECX)Call | COM | 878972108 | $5.2M | 250,000 | 0.1% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $5.3M | 692,441 | 0.1% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $5.4M | 439,142 | 0.1% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $5.4M | 453,686 | 0.1% |
| Pepgen Inc(PEPG) | COM | 713317105 | $5.4M | 829,870 | 0.1% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $5.4M | 69,935 | 0.1% |
| Biohaven LTD(BHVN)Call | COM | G1110E107 | $5.6M | 500,000 | 0.1% |
| Billiontoone Inc(BLLN) | CL A | 090168105 | $6.0M | 72,812 | 0.1% |
| Capricor Therapeutics Inc(CAPR)Call | COM NEW | 14070B309 | $7.0M | 242,100 | 0.1% |
| Kestra MED Technologies LTD(KMTS) | SHS | G52441105 | $7.6M | 285,000 | 0.1% |
| Anteris Technologies Global(AVR) | COM | 03675P102 | $8.4M | 1,675,476 | 0.1% |
| Opus Genetics Inc(IRD) | COM | 67577R102 | $8.7M | 4,325,000 | 0.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $9.0M | 200,791 | 0.2% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $9.7M | 550,000 | 0.2% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $9.7M | 3,139,669 | 0.2% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $9.9M | 493,827 | 0.2% |
| Adagio MED Hldgs Inc(ADGM) | COM | 00534B100 | $10.3M | 9,876,576 | 0.2% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $11.1M | 5,421,568 | 0.2% |
| Septerna Inc(SEPN) | COM | 81734D104 | $12.1M | 433,160 | 0.2% |
| Athira Pharma Inc(LONA) | COM | 04746L203 | $14.1M | 1,859,322 | 0.3% |
| Celcuity Inc | NOTE 2.750% 8/0 | 15102KAA8 | $14.1M | $6,500,000 | 0.3% |
| Savara Inc(SVRA) | COM | 805111101 | $14.5M | 2,400,000 | 0.3% |
| Dexcom Inc(DXCM) | COM | 252131107 | $15.0M | 225,758 | 0.3% |
| Glaukos Corp(GKOS) | COM | 377322102 | $15.8M | 140,000 | 0.3% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $16.1M | 1,903,245 | 0.3% |
| Adma Biologics Inc(ADMA) | COM | 000899104 | $16.1M | 883,468 | 0.3% |
| Guardant Health Inc(GH) | COM | 40131M109 | $16.3M | 160,000 | 0.3% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $16.7M | 1,464,592 | 0.3% |